adhered to the GFD after more than 1 year. (15) Reasons for transgressions included poorpalatability of GF foods, absence of symptoms after “cheating,” high cost of the GFD, and thenonspecified presence of gluten or erroneous affirmation of gluten absence in foods andmedications. Only 56–83 percent of teenagers with CD are considered to be on a strict GFD, (16–18)while the reported adult compliance has varied between 17 percent and 45 percent. (19,20) Patientsdiagnosed with CD via serologic mass screening in Italy showed more EMA+ and lowercompliance in comparison to age-matched patients diagnosed with “classic” symptoms duringchildhood. (21) Less than one-fourth of these patients followed a strict GFD, while 23 percent hadreturned to a normal diet after 5 years.Women with CD perceive a greater burden of illness, and express less satisfaction withthe outcome of treatment. Women are also more concerned about needing more knowledge aboutCD, interference with socializing, and the possibility that their children could get CD. Both sexesexpress bitterness over not being diagnosed earlier, believing that this could have led to betteroutcomes. (22) For many persons with CD, the major complaints are general poor health, fatigue,and a feeling of decreased well-being. (23) These symptoms may improve once the patient starts aGFD. (24) Corrao et al. published that the overall mortality in adult CD patients was double that ofthe general population, and that a delay in diagnosis, poor adherence to treatment, and severity ofsymptoms at presentation unfavorably affected patients’ outlook. (25) The GFD has been shown toimprove the quality of life even in patients with symptomless CD. (26) Patients at the time of CDdiagnosis express fear, anger, anxiety, and sadness. Anger can worsen the patient–clinicianrelationship and has been inversely correlated with dietary compliance. (27)In the United States, food labeling does not clearly state whether gluten is present ina product. The American <strong>Celiac</strong> Task Force made its debut in March 2003(http://capwiz.com/celiac/home/) to advocate for changing the food labeling law. In March 2004,the Senate passed the “Food Allergen Labeling and Consumer Protection Act.” Similarlegislation was introduced into the House in December 2003. These bills require foodmanufacturers to clearly state if a product contains the top eight food allergens (including wheat)and calls for the Food and Drug Administration to issue rules defining and permitting the term“gluten-free” on food labeling.The management of CD primarily consists of monitoring for compliance andcomplications. The patient should follow up with the gastroenterologist who performed thebiopsy once the results confirm CD, and be referred to a dietitian knowledgeable about the GFD(figure 1). Patients should be encouraged to join local chapters of national support organizations,which can aid in finding local resources such as supermarkets, food manufacturers, literature,and restaurants that are familiar with the GFD. Patients should be screened for nutritionaldeficiencies that can accompany this malabsorptive disorder and monitored for complications,including osteoporosis, neurologic complaints, other autoimmune diseases, refractory sprue,ulcerative enteritis, T-cell lymphoma, and other GI cancers. Numerous studies have documentedlow bone density in children and adults at the time of initial diagnosis of CD, which improveswith the GFD. (28–31) Children should be examined for protein–calorie malnutrition, linear growthfailure, and delayed puberty. First- and second-degree relatives should be offered screening forCD with serum antibodies.104
Patient with newly diagnosed celiacdiseaseRefer to dietitianFirst followup visit 1–2 weeks afterendoscopy with gastroenterologistRefer to supportgroupGluten-free dietcounselingFollowup with gastroenterologist orprimary care practitionerEducation aboutresourcesScreen first- and second-degree relatives for CDScreen for nutritional deficiencies:Bone density, PTHCBC, iron studies, folate, Vitamins A, E, Delectrolytes, albumin, total proteinliver enzymes, PTVitamins A, E, 25OH DFollowup visit in 3–6 months to discusscompliance with diet, monitor for complicationsand signs of other autoimmune diseases1 year after gluten-free dietCheck serum antibodies annuallyScreen for nutritional deficienciesExamine for signs and symptoms of otherautoimmune diseasesDoing poorly:Elevated antibodiesClinical symptomsNutritional deficienciesDoing well:Antibodies normalNo clinical symptomsFigure 1. An Approach to the Management of a Patient With Newly Diagnosed<strong>Celiac</strong> <strong>Disease</strong>105
- Page 1 and 2:
NIH Consensus Development Conferenc
- Page 3 and 4:
III. What Are the Manifestations an
- Page 5 and 6:
• What is the management of celia
- Page 7 and 8:
Monday, June 28, 2004 (continued)I.
- Page 9 and 10:
Monday, June 28, 2004 (continued)II
- Page 11 and 12:
Wednesday, June 30, 2004 (continued
- Page 13 and 14:
Lisa H. RichardsonConsumer Represen
- Page 15 and 16:
Ciaran P. Kelly, M.D.Director, Celi
- Page 17 and 18:
Van S. Hubbard, M.D., Ph.D.Director
- Page 19 and 20:
AbstractsThe following are abstract
- Page 21 and 22:
susceptibility (e.g., DR17 homozygo
- Page 23 and 24:
The Pathology of Celiac DiseaseDavi
- Page 25 and 26:
In this regard, the transport pathw
- Page 27 and 28:
for the IgG-based test, while speci
- Page 29 and 30:
15. de Lecea A, Ribes-Koninckx C, P
- Page 31 and 32:
Clinical Algorithm in Celiac Diseas
- Page 33 and 34:
Considera diagnosisof celiac diseas
- Page 35 and 36:
There are populations at particular
- Page 37 and 38:
Serological Testing for Celiac Dise
- Page 39 and 40:
Estimates of the sensitivity of the
- Page 41 and 42: the risk and severity of CD may als
- Page 43 and 44: What Are the Prevalence and Inciden
- Page 45 and 46: ascribed to excess menstrual loss.
- Page 47 and 48: ReferencesFamily History of Celiac
- Page 49 and 50: Carroccio A, Iannitto E, Cavataio F
- Page 51 and 52: identified by surveys or through so
- Page 53 and 54: Clinical Presentation of Celiac Dis
- Page 55 and 56: een widely reported. The question r
- Page 57 and 58: The Many Faces of Celiac Disease: C
- Page 59 and 60: References1. Green PH, Jabri B. Coe
- Page 61 and 62: Association of Celiac Disease and G
- Page 63 and 64: Does the Gluten-Free Diet Protect F
- Page 65 and 66: Skin Manifestations of Celiac Disea
- Page 67 and 68: allow a better understanding of the
- Page 69 and 70: 4. Henriksson KG, Hallert C, Walan
- Page 71 and 72: characterized, clinically-identifie
- Page 73 and 74: 10. Hoffenberg EJ, Emery LM, Barrig
- Page 75 and 76: ataxia, epilepsy with posterior cer
- Page 77 and 78: Consequences of Testing for Celiac
- Page 79 and 80: Osteoporosis/FracturesThere were 11
- Page 81 and 82: Dietary Guidelines for Celiac Disea
- Page 85 and 86: 21. Thompson T. Thiamin, riboflavin
- Page 88 and 89: In order to effectively counsel ind
- Page 90 and 91: 9. Hallert C, Granno C, Hulten S, M
- Page 94 and 95: Patient education, close supervisio
- Page 96: 26. Mustalahti K, Lohiniemi S, Laip
Change language